Chief Accounting Officer · Indivior Pharmaceuticals, Inc. · Common Stock
Side
BUY
Value
$54K
Shares
1,500
Price
$35.69
Executed
Aug 27, 2026
Disclosed
Aug 27, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Aug 27 executedAug 27, 2026 disclosed
INDV · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Anderson Woodrow D filed this Form 4 reporting a open-market purchase of INDV on Aug 27, 2026. It became public on Aug 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Accounting Officer
Anderson Woodrow Dcik:0002014440
Issuer
Indivior Pharmaceuticals, Inc.cik:0001625297
Revision history · 0
No field has changed since this record was first ingested.
